Association Between Sarcopenia and Fracture Risk in a Population From the UK Biobank Database

Studies on the fracture risk in presarcopenic and sarcopenic patients report contradictory results. The objective was to assess whether presarcopenia and sarcopenia are associated with an increase in fracture risk. We conducted a retrospective study using the UK Biobank cohort and the European Working Group on Sarcopenia in Older People 2 (EWGSOP2) criteria. Muscle strength was evaluated using hand‐grip strength (HGS) and muscle mass using the skeletal muscle index (SMI; from bioimpedance analysis). Presarcopenia was defined through the two definitions available in the literature, as low HGS with normal SMI and as normal HGS with low SMI, and sarcopenia as low HGS and low SMI. Fracture events were recorded as “fracture” (location compatible with an osteoporotic origin) and “major osteoporotic fracture” (MOF), as listed in the FRAX tool. Associations were assessed using Cox proportional hazards models, adjusted for sarcopenia and osteoporosis risk factors. Adjusted hazard ratios (HRa) and their 95% confidence intervals (CI) were reported. A total of 387,025 participants (women 54.4%; median age 58.0 years; interquartile range [IQR] 51.0–63.0 years) were included. At baseline, there were 18,257 (4.7%) presarcopenic participants—subgroup 1 (low HGS only), 7940 (2.1%) presarcopenic participants—subgroup 2 (low SMI only), and 1124 (0.3%) sarcopenic participants. Over a median follow‐up of 12.0 years (IQR 11.4–12.6 years), 18,300 (4.7%) participants were diagnosed with at least one incident fracture. Presarcopenic (subgroups 1 and 2) and sarcopenic status were significantly associated with a higher risk of fracture (respectively adjusted HRs: HR = 1.26 [1.19–1.33], HR = 1.20 [1.11–1.30], HR = 1.30 [1.08–1.56]) and with a higher risk of MOF (respectively adjusted HRs: HR = 1.30 [1.21–1.40], HR = 1.19 [1.08–1.72], HR = 1.18 [0.93–1.49]). In a middle‐aged population, the fracture and MOF risks were higher in both presarcopenic and sarcopenic participants compared with nonsarcopenic participants. © 2023 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR).

[1]  H. Zheng,et al.  Observational and genetic evidence highlight the association of human sleep behaviors with the incidence of fracture , 2021, Communications Biology.

[2]  Sang Min Park,et al.  Body composition and osteoporotic fracture using anthropometric prediction equations to assess muscle and fat masses , 2021, Journal of cachexia, sarcopenia and muscle.

[3]  J. Pell,et al.  Association of sarcopenia with incident osteoporosis: a prospective study of 168,682 UK biobank participants , 2021, Journal of cachexia, sarcopenia and muscle.

[4]  S. Ohtori,et al.  Relationship between Skeletal Muscle Mass, Bone Mineral Density, and Trabecular Bone Score in Osteoporotic Vertebral Compression Fractures , 2020, Asian spine journal.

[5]  A. Voutilainen,et al.  Handgrip strength—a risk indicator for future fractures in the general population: findings from a prospective study and meta-analysis of 19 prospective cohort studies , 2020, GeroScience.

[6]  J. Pell,et al.  Sarcopenic obesity and its association with respiratory disease incidence and mortality. , 2020, Clinical nutrition.

[7]  Jian-xiong Ma,et al.  The association between sarcopenia and fracture in middle-aged and elderly people: A systematic review and meta-analysis of cohort studies. , 2020, Injury.

[8]  L. Peng,et al.  Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. , 2020, Journal of the American Medical Directors Association.

[9]  A. Jan,et al.  BMI Classification Percentile And Cut Off Points , 2019 .

[10]  Sophie V. Eastwood,et al.  Associations Between Measures of Sarcopenic Obesity and Risk of Cardiovascular Disease and Mortality: A Cohort Study and Mendelian Randomization Analysis Using the UK Biobank , 2019, Journal of the American Heart Association.

[11]  A. Sayer,et al.  Sarcopenia , 2019, The Lancet.

[12]  René Rizzoli,et al.  Sarcopenia: revised European consensus on definition and diagnosis , 2018, Age and ageing.

[13]  M. Visser,et al.  Associations of Sarcopenia Definitions, and Their Components, With the Incidence of Recurrent Falling and Fractures: The Longitudinal Aging Study Amsterdam , 2018, The journals of gerontology. Series A, Biological sciences and medical sciences.

[14]  C. Cooper,et al.  Prior fragility fracture and risk of incident ischaemic cardiovascular events: results from UK Biobank , 2018, Osteoporosis International.

[15]  C. Cooper,et al.  Pitfalls in the measurement of muscle mass: a need for a reference standard , 2018, Journal of cachexia, sarcopenia and muscle.

[16]  J. Reginster,et al.  Health Outcomes of Sarcopenia: A Systematic Review and Meta-Analysis , 2017, PloS one.

[17]  S. Anker,et al.  Welcome to the ICD‐10 code for sarcopenia , 2016, Journal of cachexia, sarcopenia and muscle.

[18]  M. Skalski,et al.  Stress fractures: pathophysiology, clinical presentation, imaging features, and treatment options , 2016, Emergency Radiology.

[19]  S. Cummings,et al.  Evaluation of the Usefulness of Consensus Definitions of Sarcopenia in Older Men: Results from the Observational Osteoporotic Fractures in Men Cohort Study , 2015, Journal of the American Geriatrics Society.

[20]  J. Cauley,et al.  Risk of Nonspine Fractures in Older Adults with Sarcopenia, Low Bone Mass, or Both , 2015, Journal of the American Geriatrics Society.

[21]  G. Sergi,et al.  Assessing appendicular skeletal muscle mass with bioelectrical impedance analysis in free-living Caucasian older adults. , 2015, Clinical nutrition.

[22]  P. Elliott,et al.  UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age , 2015, PLoS medicine.

[23]  J. Woo,et al.  Ethnic and geographic variations in muscle mass, muscle strength and physical performance measures , 2014 .

[24]  Maren S Fragala,et al.  The FNIH Sarcopenia Project: Rationale, Study Description, Conference Recommendations, and Final Estimates , 2014, The journals of gerontology. Series A, Biological sciences and medical sciences.

[25]  S. Ima-Nirwana,et al.  Calcaneal Quantitative Ultrasound as a Determinant of Bone Health Status: What Properties of Bone Does It Reflect? , 2013, International journal of medical sciences.

[26]  S. Wyke,et al.  Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study , 2012, The Lancet.

[27]  Sung-il Cho,et al.  The association between fat and lean mass and bone mineral density: the Healthy Twin Study. , 2012, Bone.

[28]  Avan Aihie Sayer,et al.  A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach. , 2011, Age and ageing.

[29]  J. Baeyens,et al.  Sarcopenia: European consensus on definition and diagnosis , 2010, Age and ageing.

[30]  R. Ross,et al.  Estimation of skeletal muscle mass by bioelectrical impedance analysis. , 2000, Journal of applied physiology.

[31]  Lidiane Barbosa Santiago,et al.  Phase angle as a screening method for sarcopenia in community-dwelling older adults , 2022, Revista de Nutrição.

[32]  S. Boonen,et al.  Sarcopenia and its relationship with bone mineral density in middle-aged and elderly European men , 2012, Osteoporosis International.